Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loxapine in refractory chemotherapy-induced neuropathic pain
NCT02820519Phase 2Terminated
- Sponsor
- University of Witten/Herdecke
- Start
- Jun 2016
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of loxapine in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by University of Witten/Herdecke. Started Jun 2016; status: terminated.
02
Drugs
loxapine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT02820519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02820519.